Skip to content

Sentinel node in ovarian cancer

Sentinel node in ovarian cancer - SONAR study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37538
Enrollment
28
Registered
2012-09-05
Start date
2012-10-10
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignancy of the ovary ovarian cancer

Interventions

None listed

Sponsors

Medisch Universitair Ziekenhuis Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: The following patients will be included: Cohort 1: patients with a high suspicion of an ovarian malignancy in whom a median laparotomy and a frozen section analysis is planned. Cohort 2: patients with endometrial cancer in whom a staging laparotomy is planned.

Exclusion criteria

Exclusion criteria: - Previous surgery of the ovaries. - Previous vascular surgery of the aorta, caval vein, and/or iliac vessels - Previous lymphadenectomy of lymph node sampling in the iliac or para-aortal region. - History of a malignant lymphoma - History of a malignant tumour in the abdominal cavity. - Previous allergic reaction to blue dye. - Pregnant or lactating patients

Design outcomes

Primary

MeasureTime frame
Percentage of patients in whom sentinel node(s) will be identified.

Secondary

MeasureTime frame
- Location of the sentinel node(s) - Incidence of false negative nodes.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)